Remote adenoviral gene delivery to the spinal cord: Contralateral delivery and reinjection

Neurosurgery

Volumn 48, Issue 6, 2001, Pages 1309-1317

  Turner, Danielle E ^a   Noordmans, Aaron J ^a   Feldman, Eva L ^a   Boulis, Nicholas M ^b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Kresge III   (United States)

Author keywords

Adenovirus; Gene therapy; Reinjection; Sciatic nerve; Spinal cord

Indexed keywords

AD5RSVNTLACZ; FLUOROCHROME; FLUOROGOLD; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GRAY MATTER; INJECTION; INOCULATION; NERVE PROJECTION; NERVE TRANSECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL CORD; VIRUS GENE;

EID: 0034996205     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200106000-00026     Document Type: Article

References (20)

1. Boulis N, Bhatia V, Brindle T, Holman H, Krauss D, Blaivus M, Hoff J: Adenoviral gene transfer to spinal cord: A behavioral and histological analysis. J Neurosurg 90[Suppl 1]:99-108, 1999.
2. Boulis N, Turner D, Dice J, Bhatia V, Feldman E: Characterization of adenoviral gene expression in spinal cord after remote vector delivery. Neurosurgery 45:131-138, 1999.
3. Bromberg J, Debruyne L, Qin L: Interactions between the immune system and gene therapy vectors: Bidirectional regulation of response and expression. Adv Immunol 69:353-409, 1998.
4. Byrnes A, Rusby J, Wood M, Charlton H: Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66:1015-1024, 1995.
5. Glatzel M, Flechsig E, Navarro B, Klein M, Paterna J, Bueler H, Aguzzi A: Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system. Proc Natl Acad Sci U S A 97:442-447, 2000.
6. Ilan Y, Jona V, Sengupta K, Davidson A, Horwitz M, Chowdhury N, Chowdhury J: Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat. Hepatology 69:949-956, 1997.
7. Jani A, Menichella D, Jiang H, Chbihi T, Acsadi G, Shy M, Kamholz J: Modulation of cell-mediated immunity prolongs adenovirus-mediated transgene expression in sciatic nerve. Hum Gene Ther 10:787-800, 1999.
8. Kajiwara K, Byrnes A, Ohmoto Y, Charlton H, Wood M, Wood K: Humoral immune responses to adenovirus vectors in the brain. J Neuroimmunol 103:8-15, 2000.
9. Kuypers H, Ugolini R: Viruses as transneuronal tracers. Trends Neurosci 13:71-75, 1990.
10. Liu Y, Himes B, Moul J, Haung W, Chow S, Tessler A, Fischer I: Application of recombinant adenovirus for in vivo gene delivery to spinal cord. Brain Res 768:19-29, 1997.
11. Olsen L, Ayer-LeLievre C, Ebendal T, Eriksdotter-Nilsson M, Ernfors P, Henschen A, Hoffer B, Giacobini M, Palmer P, Persson H, Sara V, Stromberg I, Wetmore C: Grafts, growth factors and grafts that make growth factors. Prog Brain Res 82:55-66, 1990.
12. Ramer M, Priestley J, McMahon S: Functional regeneration of sensory axons into the adult spinal cord. Nature 403:312-316, 2000.
13. Reichel M, Ali R, Thrasher A, Hunt D, Bhattacharya S, Baker D: Immune responses limit adenovirally mediated gene expression in the adult mouse eye. Gene Ther 5:1038-1046, 1998.
14. Sato Y, Saito A, Shishido H, Irisawa A, Miyata M, Nishimaki T, Fujita T, Suzuki T, Kasukawa R: Injection of plasmid DNA into the gastric mucosa induces mucosal and systemic immunity. Cell Immunol 199:58-63, 2000.
15. Smith G, Romero M: Adenoviral-mediated gene transfer to enhance neuronal survival, growth, and regeneration. J Neurosci Res 55:147-157, 1999.
16. Takahasi M, Ilan Y, Chowdhury N, Guida J, Horwitz M, Chowdhury J: Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of recombinant adenovirus during the neonatal period. J Biol Chem 271:26536-26542, 1996.
17. Ueno H: Adenoviurs-mediated gene transfer into injured arteries: Quantitative analysis of repeated administration. Gerontology 42:25-36, 1996.
18. Yang Y, Li Q, Ertl H, Wilson J: Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69:2004-2015, 1995.
19. Yei S, Mittereder N, Wert S, Whitesett J, Wilmott R, Trapnell B: In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum Gene Ther 5:733-746, 1994.
20. Zabner J, Petersen D, Puga A, Graham S, Couture L, Keyes L, Lukason M, George JS, Gregory R, Smith A, Welsh M: Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet 6:75-83, 1994.